Streetbeat News

Price Targets

ALNY

Needham analyst Joseph Stringer has reiterated a 'Buy' rating on Alnylam Pharmaceuticals (NASDAQ:ALNY) and maintained a price target of $240.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 10:18 am

DAWN

Needham analyst Ami Fadia has reiterated a 'Buy' rating on Day One Biopharmaceutical (NASDAQ:DAWN) and maintained a price target of $34.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 10:16 am

MEG

Needham analyst James Ricchiuti has reiterated a 'Buy' rating on Montrose Environmental Gr (NYSE:MEG) and maintained a price target of $54.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 10:12 am

MLTX

Needham analyst Serge Belanger has reiterated a 'Buy' rating on MoonLake (NASDAQ:MLTX) and maintained a price target of $76.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 10:11 am

IFRX

HC Wainwright & Co. analyst Edward White has reiterated a 'Buy' rating on InflaRx (NASDAQ:IFRX), maintaining a price target of $9.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 10:11 am

AMAM

BTIG analyst Kaveri Pohlman has initiated coverage on Ambrx Biopharma (NASDAQ:AMAM) with a Buy rating and a price target of $26.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 9:57 am

BGNE

RBC Capital analyst Jake Lynch has initiated coverage on BeiGene (NASDAQ:BGNE) with an Outperform rating and a price target of $259.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 9:56 am

BTG

RBC Capital analyst Josh Wolfson has assumed coverage of B2Gold (AMEX:BTG) with a Sector Perform rating and a price target of $4.25.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 9:52 am

GB

Deutsche Bank analyst Nate Svensson has initiated coverage on Global Blue Gr Holding (NYSE:GB) with a Buy rating and a price target of $8.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 9:48 am

ENPH

Truist Securities analyst Jordan Levy has downgraded Enphase Energy (NASDAQ:ENPH) from Buy to Hold and lowered the price target from $210 to $135.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 9:47 am